Special Issue

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

28 Oct 2016
Rosa A van Amerongen, Valesca P Retèl, Veerle MH Coupé, Petra M Nederlof, Maartje J Vogel, Wim H van Harten

Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these costs. In this study, we give an estimation of the costs and an institutional and national budget impact of various types of NGS tests in non-small-cell lung cancer (NSCLC) and melanoma patients within the Netherlands. First, an activity-based costing (ABC) analysis has been conducted on the costs of two examples of NGS panels (small- and medium-targeted gene panel (TGP)) based on data of the Netherlands Cancer Institute (NKI). Second, we performed a budget impact analysis (BIA) to estimate the current (2015) and future (2020) budget impact of NGS on molecular diagnostics for NSCLC and melanoma patients in the Netherlands. Literature, expert opinions, and a data set of patients within the NKI (n = 172) have been included in the BIA. Based on our analysis, we expect that the NGS cost concerns will be limited. In the current situation, NGS can indeed result in higher costs, which is mainly related to required additional tests besides the small TGP. However, in the future, we expect that the use of whole-genome sequencing (WGS) will increase, for which it is expected that additional tests can by (partly) avoided. Although the current clinical benefits are expected to be limited, the research potentials of NGS are already an important advantage.

Article metrics: 3129 views

Related Articles

Lekha Madhavan Nair, KM Jagathnath Krishna, Aswin Kumar, Susan Mathews, John Joseph, Francis Vadakkumparambil James
Hugo Tanaka, Deise Uema, Juliana FM Rego, Rui F Weschenfelder, Nathalia D’Agustini, Duilio R Rocha Filho, Juan M O'Connor, Romina Luca, Jose Eduardo R Nuñez, Milton José de Barros e Silva, Rachel P Riechelmann
Justin Yeh, Shruti Gupta, Sunny J Patel, Vamsi Kota, Achuta K Guddati
Ana Karla Uribe Rivera, Andres Guevara Jabiles, Ivan Chavez Passiuri, Elica Garcia Leon, Melvy Guerrero Quiroga, Renier Cruz Baca, Jossue Espinoza Figueroa, Nelson Purizaca Rosillo, Eduardo Payet Meza
Annu Rajpurohit, Nilendu Purandare, Aliasgar Moiyadi, Prakash Shetty, Abhishek Mahajan, Rajiv Kumar, Subhash Yadav, Naveen Munmudi, Ameya Puranik, Anil Tibdewal, Rahul Krishnarthy, Ankita Ahuja, Nandini Menon, Vanita Noronha, Amit Joshi, Vijay M Patil, Kumar Prabhash